Literature DB >> 2029580

Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes.

D K Blanchard1, M B Michelini-Norris, C A Pearson, C S Freitag, J Y Djeu.   

Abstract

Mycobacterium avium-intracellulare (MAI) is an opportunistic pathogen commonly found in acquired immunodeficiency syndrome patients, whose immune systems are severely compromised. However, normal responses to this bacterium are apparently sufficient to prevent disseminated infection because disease is rarely found unless an immunocompromised state is present. Because interleukin-6 (IL-6) is an inflammatory cytokine with a multitude of activities, we investigated the potential of MAI to induce IL-6 from normal human leukocytes. Peripheral blood mononuclear cells were fractionated into monocytes (Mo), large granular lymphocytes (LGL), and T cells and stimulated with bacteria. Culture supernatants were collected and assayed for IL-6 activity by bioassay. Mo and LGL, but not T cells, were found to release IL-6 within 12 hours of stimulation, with optimal production occurring by 2 days of culture. Production of IL-6 from human leukocyte subsets was confirmed by Northern blot analysis and by neutralization of biologic function of the culture supernatants with specific antisera. Taken together, these results indicate that production of IL-6 is a key response of Mo and LGL to MAI. The role of IL-6 in MAI infection, therefore, needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029580

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

2.  Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.

Authors:  D V Havlir; F J Torriani; R D Schrier; J Y Huang; M M Lederman; K A Chervenak; W H Boom
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression.

Authors:  D K Blanchard; S McMillen; S L Hoffman; J Y Djeu
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.

Authors:  L E Bermudez; M Wu; L S Young
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 5.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.

Authors:  L E Bermudez; M Wu; M Petrofsky; L S Young
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum.

Authors:  G S Douvas; M H May; E Ross; A J Crowle
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Release of TNF alpha and IL6 from human monocytes infected with Mycobacterium kansasii: a comparison to Mycobacterium avium.

Authors:  F Stauffer; E P Petrow; H Burgmann; W Graninger; A Georgopoulos
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

9.  Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.

Authors:  J Champsi; L S Young; L E Bermudez
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

10.  Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.

Authors:  R Appelberg; A G Castro; J Pedrosa; P Minóprio
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.